160 related articles for article (PubMed ID: 12704669)
21. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis.
Shetty S; Kumar A; Johnson A; Pueblitz S; Idell S
Am J Physiol; 1995 Jun; 268(6 Pt 1):L972-82. PubMed ID: 7611439
[TBL] [Abstract][Full Text] [Related]
22. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells.
Liu G; Shuman MA; Cohen RL
Int J Cancer; 1995 Feb; 60(4):501-6. PubMed ID: 7829264
[TBL] [Abstract][Full Text] [Related]
23. Regulation and role of urokinase plasminogen activator in vascular remodelling.
Tkachuk V; Stepanova V; Little PJ; Bobik A
Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):759-65. PubMed ID: 8911711
[TBL] [Abstract][Full Text] [Related]
24. Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients.
Pappot H; Høyer-Hansen G; Rønne E; Hansen HH; Brünner N; Danø K; Grøndahl-Hansen J
Eur J Cancer; 1997 May; 33(6):867-72. PubMed ID: 9291807
[TBL] [Abstract][Full Text] [Related]
25. Occupancy of the cancer cell urokinase receptor (uPAR): effects of acid elution and exogenous uPA on cell surface urokinase (uPA).
Baker MS; Liang XM; Doe WF
Biochim Biophys Acta; 1992 Sep; 1117(2):143-52. PubMed ID: 1381963
[TBL] [Abstract][Full Text] [Related]
26. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
Picone R; Kajtaniak EL; Nielsen LS; Behrendt N; Mastronicola MR; Cubellis MV; Stoppelli MP; Pedersen S; Danø K; Blasi F
J Cell Biol; 1989 Feb; 108(2):693-702. PubMed ID: 2537321
[TBL] [Abstract][Full Text] [Related]
27. Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT1080 sarcoma cells.
Laug WE; Wang K; Mundi R; Rideout W; Kruithof EK; Bogenmann E
Int J Cancer; 1992 Sep; 52(2):298-304. PubMed ID: 1325952
[TBL] [Abstract][Full Text] [Related]
28. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.
Wang Y; Dang J; Liang X; Doe WF
Clin Exp Metastasis; 1995 May; 13(3):196-202. PubMed ID: 7750207
[TBL] [Abstract][Full Text] [Related]
29. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function.
Fischer K; Lutz V; Wilhelm O; Schmitt M; Graeff H; Heiss P; Nishiguchi T; Harbeck N; Kessler H; Luther T; Magdolen V; Reuning U
FEBS Lett; 1998 Oct; 438(1-2):101-5. PubMed ID: 9821967
[TBL] [Abstract][Full Text] [Related]
30. Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor.
Shetty S; Kumar A; Johnson AR; Idell S
Antisense Res Dev; 1995; 5(4):307-14. PubMed ID: 8746780
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells.
Mandriota SJ; Seghezzi G; Vassalli JD; Ferrara N; Wasi S; Mazzieri R; Mignatti P; Pepper MS
J Biol Chem; 1995 Apr; 270(17):9709-16. PubMed ID: 7730348
[TBL] [Abstract][Full Text] [Related]
32. Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.
Bhandary YP; Velusamy T; Shetty P; Shetty RS; Idell S; Cines DB; Jain D; Bdeir K; Abraham E; Tsuruta Y; Shetty S
Am J Respir Crit Care Med; 2009 Feb; 179(4):288-98. PubMed ID: 19029002
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides.
Bürgle M; Koppitz M; Riemer C; Kessler H; König B; Weidle UH; Kellermann J; Lottspeich F; Graeff H; Schmitt M; Goretzki L; Reuning U; Wilhelm O; Magdolen V
Biol Chem; 1997; 378(3-4):231-7. PubMed ID: 9165076
[TBL] [Abstract][Full Text] [Related]
34. Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system.
Behrendt N; Danø K
FEBS Lett; 1996 Sep; 393(1):31-6. PubMed ID: 8804418
[TBL] [Abstract][Full Text] [Related]
35. Gene expression of plasminogen activation cascade components in human term gestational tissues with labour onset.
Tsatas D; Baker MS; Moses EK; Rice GE
Mol Hum Reprod; 1998 Jan; 4(1):101-6. PubMed ID: 9510019
[TBL] [Abstract][Full Text] [Related]
36. Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry.
Kennedy S; Duffy MJ; Duggan C; Barnes C; Rafferty R; Kramer MD
Br J Cancer; 1998 May; 77(10):1638-41. PubMed ID: 9635840
[TBL] [Abstract][Full Text] [Related]
37. Detection of the receptor for the human urokinase-type plasminogen activator using fluoresceinated uPA.
Ciccocioppo R; Capri MG; Alberti S
J Histochem Cytochem; 1997 Sep; 45(9):1307-13. PubMed ID: 9283618
[TBL] [Abstract][Full Text] [Related]
38. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.
Bernstein AM; Twining SS; Warejcka DJ; Tall E; Masur SK
Mol Biol Cell; 2007 Jul; 18(7):2716-27. PubMed ID: 17507651
[TBL] [Abstract][Full Text] [Related]
39. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
Antalis TM; Reeder JA
Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
[TBL] [Abstract][Full Text] [Related]
40. The receptor for urokinase-type plasminogen activator is expressed during mouse spermatogenesis.
Zhou H; Vassalli JD
FEBS Lett; 1997 Aug; 413(1):11-5. PubMed ID: 9287108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
